$RGNX stock has now fallen 24% today, according to our price data from Polygon. There has been approximately $13,035,809 of trading volume.
Here is what we see in our data on $RGNX (you can track the company live on Quiver's $RGNX stock page):
$RGNX Insider Trading Activity
$RGNX insiders have traded $RGNX stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $RGNX stock by insiders over the last 6 months:
- STEVE PAKOLA (Chief Medical Officer) has made 0 purchases and 5 sales selling 78,927 shares for an estimated $939,970.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$RGNX Hedge Fund Activity
We have seen 83 institutional investors add shares of $RGNX stock to their portfolio, and 106 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 2,214,169 shares (+inf%) to their portfolio in Q2 2026, for an estimated $26,525,744
- QUBE RESEARCH & TECHNOLOGIES LTD removed 1,310,493 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $15,699,706
- MARSHALL WACE, LLP added 1,284,950 shares (+inf%) to their portfolio in Q2 2026, for an estimated $15,393,701
- INTEGRAL HEALTH ASSET MANAGEMENT, LLC removed 700,000 shares (-46.7%) from their portfolio in Q2 2026, for an estimated $8,386,000
- CITADEL ADVISORS LLC added 669,023 shares (+inf%) to their portfolio in Q2 2026, for an estimated $8,014,895
- D. E. SHAW & CO., INC. added 644,426 shares (+942.3%) to their portfolio in Q2 2026, for an estimated $7,720,223
- BLACKROCK, INC. added 614,632 shares (+10.6%) to their portfolio in Q2 2026, for an estimated $7,363,291
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$RGNX Price Targets
Multiple analysts have issued price targets for $RGNX recently. We have seen 6 analysts offer price targets for $RGNX in the last 6 months, with a median target of $17.5.
Here are some recent targets:
- Yi Chen from HC Wainwright & Co. set a target price of $26.0 on 06/24/2026
- Brian Skorney from Baird set a target price of $32.0 on 06/22/2026
- Mani Foroohar from Leerink Partners set a target price of $18.0 on 06/22/2026
- Gena Wang from Barclays set a target price of $12.0 on 05/15/2026
- Geoff Meacham from B of A Securities set a target price of $14.0 on 05/15/2026
- Judah Frommer from Morgan Stanley set a target price of $17.0 on 03/06/2026
You can track data on $RGNX on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
